Ex-KKR dealmaker launches healthcare-focused buyout firm
DeeperDive is a beta AI feature. Refer to full articles for the facts.
[NEW YORK] Jim Momtazee, a former dealmaker at US buyout firm KKR & Co, has launched his own firm to pursue private equity deals in the healthcare sector.
Mr Momtazee, who spent 21 years at KKR and led its Americas healthcare team for a decade, said in a statement he formed Patient Square Capital together with Maria Walker, a former partner at consulting firm KPMG.
The move comes as the outbreak of the novel coronavirus has strained some healthcare providers, while spurring growth in some sectors such as telemedicine and vaccine production.
Patient Square Capital plans to look for deals across the healthcare industry, including technology-enabled services, biopharmaceuticals, the pharmaceutical value chain, medical devices, diagnostics, providers, digital health and consumer health, the statement said.
"We're going to be broad-based in our focus on all aspects of healthcare, bringing depth of knowledge, scale, expertise, and long-term view to our investments," Mr Momtazee told Reuters in an interview.
Prior to leaving KKR last year, Mr Momtazee worked on some of the buyout firm's biggest healthcare deals, including the US$33 billion take-private of US hospital operator HCA Healthcare, as well as the acquisition of contract research firm PRA International for US$1.3 billion in 2013.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
REUTERS
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Share with us your feedback on BT's products and services
TRENDING NOW
Autobahn Rent A Car directors declared bankrupt over S$50 million each owed to DBS
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
Loyang Valley sold for S$880 million to SingHaiyi-led consortium